Lower drug sales potential at Bayer underscores need for deals

Germany's Bayer , which acquired seed company Monsanto this year, reduced its combined sales estimate for its most promising experimental drugs, acknowledging it needs to do more to replenish the development pipeline.

from Reuters: Business News https://ift.tt/2QfQ2NO